The interaction of new 4,9-diazapyrenium compounds with double stranded nucleic acids

Journal of the Chemical Society. Perkin Transactions 2

Volumn , Issue 2, 2000, Pages 385-392

  Palm, Barbara Susanne ^a   Piantanida, Ivo ^a   Žinič, Mladen ^a   Schneider, Hans Jörg ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; ELECTROSTATICS; FLUORESCENCE; INTERCALATION COMPOUNDS; MELTING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEIC ACIDS; TITRATION; VISCOSITY MEASUREMENT;

DENATURATION POINT; DIAZAPYRENIUM COMPOUNDS; ETHIDIUM BROMIDE; LIGANDS; SCATCHARD ANALYSIS; XYLYLENE;

ORGANIC COMPOUNDS;

EID: 0034143065     PISSN: 03009580     EISSN: None     Source Type: Journal    
DOI: 10.1039/a905307g     Document Type: Article

References (60)

1. (a) W. Saenger, Principles of Nucleic Acid Structure, Springer, New York 1988
2. (b) W. D. Wilson, in Nucleic Acids in Chemistry and Biology, ed. M. Blackburn and M. Gait, IRL Press, Oxford, 1989, ch. 8
3. (c) J. W. Lown Anti-Cancer Drug Des., 1988, 3, 25
4. (d) P. B. Dervan, Science, 1986, 232, 464
5. (e) S. Neidle and T. C. Jenkins, Molecular Design and Modeling, Part B, 1991, 203, 433
6. (f) D. S. Johnson and D. L. Boger, DNA Binding Agents, ch. 3, in Comprehensive Supramolecular Chemistry, vol. 4, series ed. J.-M. Lehn, vol. ed. Y. Murakami, Pergamon Press, Oxford, England, 1996, 73.
7. (a) P. Hobza, J. Sponer, and M. Polasek, J. Am. Chem. Soc., 1995, 117, 792
8. J. Sponer, J. Lesczynski and P. Hobza, J. Phys. Chem., 1996, 100, 5590
9. (b) J. Sponer and P. Hobza, Int. J. Quant. Chem., 1996, 57, 959
10. (c) J. Sponer, J. Lesczynski, V. Vetter and P. Hobza, J. Biomol. Struct. Dyn., 1996, 13, 695
11. (d) R. A. Friedmann and B. Honig, Biopolymers, 1992, 32, 145
12. (e) P. Hobza, M. Kabelaz, J. Sponer, P. Meijzlik and J. Vandrasek, J. Comput. Chem., 1997, 18, 113
13. (f) H.-J. Schneider and J. Sartorius, in Physical Supramolecular Chemistry, eds. L. Echegoen and A. E. Kaifer, (NATO ASI Ser. C) 1996, p. 11; and references cited therein.
14. References on RNA interactions with small ligands, see (a) Li Ke, M. Fernandez-Saiz, C. T. Rigl, A. Kumar, K. G. Ragunathan, A. W. C. McConnaughie, D. W. Boykin, H.-J. Schneider and W. D. Wilson, in Bioorganic and Medicinal Chemistry; Symposium Issue "Strategies for RNA Recognition", ed. S. Hecht, 1997
15. D. W. Wilson, Y. Li and J. Veal, in Advances in DNA Sequence Specific Agents, vol. 1, p. 89; ed. L. H. Hurley, JAI Press, Inc., Greenwich, 1992.
16. W. D. Wilson, L. Ratmeyer, M. Zhao, L. Strekowski and D. Boykin, Biochemistry, 1993, 32, 4098.
17. I. Piantanida, V. Tomišič and M. Žinič, J. Chem. Soc., Perkin Trans. 2, 2000, preceding article.
18. (a) L. Strekowski, J. L. Mokrosz, W. D. Wilson, M. J. Mokrosz and A. Strekowski, Biochemistry, 1992, 31, 10802
19. (b) A. J. Hopfinger, M. G. Cardozo and Y. Kawakami, J. Chem. Soc., Faraday Trans., 1995, 91, 2515
20. (c) H.-J. Schneider and J. Sartorius J. Chem. Soc., Perkin Trans. 2, 1997, 2319 and references cited therein.
21. J. Blacker, J. Jazwinski and J.-M. Lehn, Helv. Chim. Acta, 1987, 70, 1
22. J. Blacker, J. Jazwinski, J.-M. Lehn and F. X. Wilhelm, J. Chem. Soc., Chem. Commun., 1986, 1035
23. A. Slama-Schwok, J. Jazwinski, A. Bere, T. Montenay-Garestier, M. Rougée, C. Hélène and J.-M. Lehn, Biochemistry, 1989, 8, 3227
24. A. Slama-Schwok, M. Rougée, V. Ibanez, N. E. Geacintov, T. Montenay-Garestier, J.-M. Lehn and C. Hélène, Biochemistry 1989, 8, 3234.
25. A. M. Brun and A. Harriman J. Am. Chem. Soc., 1991, 113, 8153
26. C. Coudret and A. Harriman, J. Chem. Soc., Chem. Commun., 1992, 1755.
27. L. Kibler-Herzog, B. Kell, G. Zon, K. Shinozuka, S. Mizan and W. D. Wilson, Nucleic Acids Res., 1990, 18, 3545.
28. (a) C. R. Cantor and P. R. Schimmel, Biophysical Chemistry, Part III, W. H. Freeman and Co. 1980, p. 1233
29. (b) H. W. Zimmermann, Angew. Chem., Int. Ed. Engl., 1986, 25, 115
30. (c) J. D. McGhee and P. H. von Hippel 1974, 86, 469 and 1976, 103, 679.
31. S. Chandrasekaran, S. Kusuma, D. W. Boykin and W. D. Wilson, Magn. Res. Chem., 1986, 24, 630
32. J. Sartorius and H.-J. Schneider, FEBS Lett., 1995, 374, 387.
33. M. Wirth, O. Burchardt, T. Koch, P. E. Nielsen and B. Norden, J. Am. Chem. Soc., 1988, 110, 932.
34. S. F. Yen, E. J. Gabbay and W. D. Wilson, Biochemistry, 1982, 21, 2070
35. W. D. Wilson and F. A. Tanious, in Molecular Aspects of Anticancer Drug-DNA Interactions, ed. S. Neidle and M. J. Waring, Macmillan Press, Riverside, N.Y.
36. F. A. Tanious, S. F. Yen and W. D. Wilson, Biochemistry, 1991, 30, 1813
37. W. Müller and D. M. Crothers, J. Mol. Biol., 1968, 35, 251
38. J. A. Elliot, W. D. Wilson, R. G. Shea, J. A. Hartley, K. Reszka and J. W. Lown, Anti-cancer Drug Design, 1989, 3, 271.
39. C. R. Cantor and P. R. Schimmel, Biophysical Chemistry, Part III, W. H. Freeman and Co. 1980, p. 1137-44
40. C. L. Stevens and G. Felsenfeld, Biopolymers, 1964, 2, 293.
41. R. Lauceri, T. Campagna, A. Contino and R. Purrello, Angew. Chem., Int. Ed. Engl., 1996, 35, 215.
42. J. M. Waring Biochem. J., 1974, 143, 483.
43. J. Mergny, D. Collier, M. Rougée, T. Montenay-Garestier and C. Hélène, Nucleic Acids Res., 1991, 19, 1521
44. N. T. Thuong and C. Hélène Angew. Chem., Int. Ed. Engl., 1993, 32, 666.
45. D. S. Pilch and K. J. Breslauer, Proc. Natl. Acad. Sci. USA, 1994, 91, 9332.
46. W. Saenger, Principles of Nucleic Acid Structure, 1980, p. 305.
47. C. R. Cantor and P. R. Schimmel, Biophysical Chemistry, Part III, W. H. Freman and Co. 1980, p. 1144.
48. C. R. Cantor and P. R. Schimmel, Biophysical Chemistry, Part III, W. H. Freeman and Co. 1980, p. 1135.
49. A. Czarny, D. W. Boykin, A. A. Wood, C. M. Nunn, S. Neidle, M. Zhao and W. D. Wilson, J. Am. Chem. Soc., 1995, 117, 4716.
50. D. L. Boger and D. S. Johnson Angew. Chem., Int. Ed. Engl., 1996, 108, 1439 and references herein
51. D. L. Boger and D. S. Johnson, Proc. Natl. Acad. Sci. USA, 1995, 92, 3642.
52. L. P. G. Wakelin, M. Romanos, T. K. Chen, D. Glaubiger, E. S. Canellakis and W. J. Waring, Biochemistry, 1978, 17, 5057
53. L. P. G. Wakelin Med. Res. Rev., 1986, 6, 273 and references herein.
54. M. Cory, D. D. McKee, J. Kagan, D. W. Henry and J. A. Miller, J. Am. Chem. Soc., 1985, 107, 2528
55. S. C. Zimmerman, C. R. Lamberson, M. Cory and T. A. Fairley, J. Am. Chem. Soc., 1989, 111, 6805
56. J. M. Veal, Y. Li, S. C. Zimmerman, C. R. Lamberson, M. Cory, G. Zon and W. D. Wilson, Biochemistry 1990, 29, 10918.
57. D. B. Davies, L. N. Djimant and A. N. Veselkov, J. Chem. Soc., Faraday Trans., 1996, 92(3), 383.
58. W. D. Wilson, F. A. Tanious, M. Fernandez-Saiz and C. T. Rigl, Evaluation of Drug/Nucleic acid Interactions by Thermal Melting Curve, from: Methods in Molecular Biology, Vol. 90: Drug-DNA Interaction Protocols, ed. K. R. Fox, Humana Press Inc., Totowa, N.Y.
59. G. Cochen and H. Eisenberg Biopolymers, 1969, 8, 45
60. M. Wirth, O. Buchardt, T. Koch, P. E. Nielsen and B. Nordén, J. Am. Chem. Soc., 1988, 110, 932.